Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-07

FDA Approved: NEBIVOLOL — Original Application (Solco Healthcare US, LLC)

View source ↗

Summary

The FDA approved the original application for Nebivolol (generic) from Solco Healthcare US, LLC. Nebivolol is used to treat hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol (Nebivolol)

Snippet

ORIG AP for NEBIVOLOL (NEBIVOLOL)